| |
|
|
|
Applied DNA Sciences Inc.  
|
|
0.3393 -0.007 (-0.02%) |
07-19 16:00 |
|
Open: |
0.37 |
Pre close: |
0.346 |
Target:
|
0.63
|
|
High: |
0.4002 |
Low: |
0.3375 |
Resistance:
|
0.54
0.67
|
|
Volume: |
2,654,986 |
Market Cap: |
13M |
Support:
|
0.33
0.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.44
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.51 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
0.60 |
Stochastic Oscillator |
%K(14,3):
|
8.67 |
|
MA(250): |
0.85 |
%D(3): |
13.16 |
|
Average Volume(K) |
3-Month: |
34347
|
52-Week |
High:
|
1.84 |
|
10-Days: |
69506 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
19.45 |
Change(%): |
-75.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.369 |
Return on Equity (ttm) |
-494.0 |
Shares Out. (M) |
30.11 |
|
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-125.0 |
Shares Float (M) |
29.27 |
|
EPS Est. Next Year |
-0.230 |
PEG Ratio |
0.00 |
% Held by Insiders |
23.39 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-25.4 |
% Held by Institutions |
5.05 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.090 |
Shares Short (K) |
1950 |
|
Book Value (p.s.) |
-0.020 |
EBITDA (p.s.) |
-0.388 |
P/E |
-0.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-16.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.44 |
P/S |
85136024.00 |
|
Operating Margin |
-313.86 |
Levered Free Cash Flow
(M) |
-3.95 |
P/CF |
-1.37 |
|
|
|
|
|
|
